Alison Massey

2.5k total citations
21 papers, 1.4k citations indexed

About

Alison Massey is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alison Massey has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alison Massey's work include Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (8 papers) and Colorectal and Anal Carcinomas (5 papers). Alison Massey is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (8 papers) and Colorectal and Anal Carcinomas (5 papers). Alison Massey collaborates with scholars based in United Kingdom, Australia and Germany. Alison Massey's co-authors include David Cunningham, Lloyd S. Peck, Melody S. Clark, Ian Chau, A. Norman, J. Oates, Gina Brown, Andrew Wotherspoon, Diana Tait and Simon A. Morley and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and British Journal of Cancer.

In The Last Decade

Alison Massey

21 papers receiving 1.4k citations

Peers

Countries citing papers authored by Alison Massey

Since Specialization

Citations

This map shows the geographic impact of Alison Massey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Massey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Massey more than expected).

Fields of papers citing papers by Alison Massey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Massey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Massey. The network helps show where Alison Massey may publish in the future.

Co-authorship network of co-authors of Alison Massey

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Massey. A scholar is included among the top collaborators of Alison Massey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Massey. Alison Massey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	4 The promotion of successful advance care planning (ACP) for care home residents during the Covid-19 pandemic 2021 ·Oral Presentations ·(unknown), (unknown), Alison Massey, (unknown), (unknown), (unknown), (unknown)	1
2	Surveys reveal increasing and globally important populations of south polar skuas and Antarctic shags in Ryder Bay (Antarctic Peninsula) 2018 ·Polar Biology ·Richard A. Phillips, Janet R. D. Silk, Alison Massey, Kevin A. Hughes	10
3	Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial 2010 ·The Lancet Oncology ·Yu Jo Chua, Yolanda Barbáchano, David Cunningham, Jacqui Oates, Gina Brown, Andrew Wotherspoon, Diana Tait, Alison Massey, Niall C. Tebbutt, Ian Chau	233
4	Animal temperature limits and ecological relevance: effects of size, activity and rates of change 2009 ·Functional Ecology ·Lloyd S. Peck, Melody S. Clark, Simon A. Morley, Alison Massey, (unknown)	283
5	Lack of acclimation in Ophionotus victoriae: brittle stars are not fish 2008 ·Polar Biology ·Lloyd S. Peck, Alison Massey, Michael A. S. Thorne, Melody S. Clark	58
6	Gefitinib and irinotecan in patients with fluoropyrimidine-refractory, irinotecan-naive advanced colorectal cancer: a phase I–II study 2007 ·Annals of Oncology ·Ian Chau, David Cunningham, Tamas Hickish, Alison Massey, (unknown), Richard H. Osborne, N. Botwood, Alan Swaisland	31
7	Developing a saltmarsh classification tool for the European water framework directive 2006 ·Marine Pollution Bulletin ·Mike Best, Alison Massey, (unknown)	23
8	Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer 2006 ·Journal of Clinical Oncology ·Ian Chau, Gina Brown, David Cunningham, Diana Tait, Andrew Wotherspoon, A. Norman, Niall C. Tebbutt, Mark Hill, Paul J. Ross, Alison Massey, J. Oates	324
9	CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials 2005 ·British Journal of Cancer ·N. Maisey, A. Norman, A Hill, Alison Massey, J. Oates, David Cunningham	125
10	Phase I study of the humanized epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with ECX (epirubicin, cisplatin and capecitabine) as first line treatment for advanced oesophagogastric (OG) adenocarcinoma 2005 ·Journal of Clinical Oncology ·Stephen M. Rao, Naureen Starling, (unknown), Alison Massey, A. Wotherspoon, Gina Brown, (unknown), J. Tillner, Dirk Weber, David Cunningham	14
11	Phase I study of gefitinib in combination with irinotecan in patients with fluoropyrimidine refractory advanced colorectal cancer (CRC) 2004 ·Journal of Clinical Oncology ·Ian Chau, Alison Massey, (unknown), N. Botwood, David Cunningham	10
12	A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer 2003 ·Annals of Oncology ·Helen Mackay, Mark Hill, Chris Twelves, Rosalind Glasspool, Timothy Price, (unknown), Alison Massey, (unknown), (unknown), (unknown), Christophe Martin, David Cunningham	28
13	A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primary 2003 ·European Journal of Cancer ·L. Assersohn, A. Norman, David Cunningham, Timothy Iveson, Michel Seymour, Tamas Hickish, Alison Massey, (unknown), Mark Hill	15
14	Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer 2003 ·British Journal of Cancer ·Ian Chau, Mark Allen, David Cunningham, Diana Tait, Gina Brown, Mark Hill, Kate Sumpter, Anthony Rhodes, Andrew Wotherspoon, A. Norman, A Hill, Alison Massey, (unknown)	65
15	305 Twelve weeks of neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation (CRT) and total mesorectal excision (TME) in MRI defined poor risk locally advanced rectal cancer resulted in promising tumour regression and rapid symptomatic relief 2003 ·European Journal of Cancer Supplements ·Ian Chau, David Cunningham, (unknown), Gina Brown, Niall C. Tebbutt, Maureen V. Hill, Andrew Wotherspoon, Alyson Norman, Alison Massey, J. Oates	9
16	Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer 2001 ·British Journal of Cancer ·Ian Chau, Andrew Webb, David Cunningham, Mark Hill, Justin S. Waters, A. Norman, Alison Massey	20
17	Phase I study of irinotecan and raltitrexed in patients with advanced astrointestinal tract adenocarcinoma 2000 ·British Journal of Cancer ·Hugo Ford, David Cunningham, Paul J. Ross, Shuan Rao, G. Wynne Aherne, T. Benepal, Timothy Price, Alison Massey, Laurent Vernillet	21
18	A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer 1997 ·Annals of Oncology ·Paul J. Ross, A. Norman, David Cunningham, Andrew Webb, Timothy Iveson, Anwar R. Padhani, J Prendiville, Maggie Watson, Alison Massey, Răzvan Popescu, J. Oates	107
19	New innovative treatment in metastatic colorectal cancer 1997 ·International Journal of Palliative Nursing ·Alison Massey	1
20	A prospective randomlsed trial of protracted venous infusion (PVI) 5-FU with or without mitomycin C (MMC) in advanced colorectal cancer 1997 ·European Journal of Cancer ·Paul J. Ross, A. R. Norman, David Cunningham, A. Webb, Timothy Iveson, Anwar R. Padhani, Alison Massey	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact